compet
interest
fgdr
gdp
speaker
advisori
board
member
pfizer
vmr
receiv
fund
pfizer
author
declar
compet
interest
ethic
approv
ethic
approv
given
ethic
committe
giovanni
battistamolinett
hospit
sir
recent
review
global
epidemiolog
meticillinresist
staphylococcu
aureu
mrsa
stefani
et
al
show
mrsa
remain
highli
preval
hospit
especi
america
asia
malta
contrast
preval
hospitalacquir
mrsa
declin
austria
franc
ireland
uk
greec
howev
anoth
recent
studi
enrol
hospit
europ
north
america
south
america
period
demonstr
incid
nosocomi
bloodstream
infect
bsi
increas
increas
incid
mainli
due
antibioticresist
bacteria
arb
includ
mrsa
studi
mrsa
incid
densiti
event
per
patientday
increas
annual
increas
seven
arbendem
hospit
taiwan
annual
report
taiwan
nosocomi
infect
surveil
system
depart
health
taiwan
show
aureu
among
top
three
common
pathogen
caus
bsi
intens
care
unit
aureu
isol
mrsa
differ
mrsa
incid
densiti
may
due
geograph
variat
find
might
generalis
place
asia
therefor
retrospect
assess
trend
incid
nosocomi
mrsa
bsi
arbendem
medic
centr
taiwan
studi
conduct
nation
taiwan
univers
hospit
ntuh
academ
affili
medic
centr
provid
primari
tertiari
care
northern
taiwan
number
annual
patientday
hospit
increas
determin
tempor
trend
nosocomi
bsi
due
mrsa
ntuh
data
disk
diffus
suscept
aureu
oxacillin
among
isol
recov
retriev
annual
summari
document
definit
nosocomi
infect
follow
nation
nosocomi
infect
surveil
guidelin
isol
speci
patient
recov
within
day
consid
singl
isol
suscept
test
aureu
follow
clinic
laboratori
standard
institut
clsi
guidelin
staphylococcu
aureu
atcc
use
control
strain
routin
disk
suscept
test
meticillin
resist
among
aureu
isol
routin
screen
measur
growth
isol
trypticas
soy
agar
plate
contain
mgl
oxacillin
plu
nacl
c
ambient
air
h
test
use
dichotom
variabl
test
trend
use
assess
tempor
trend
incid
densiti
poisson
regress
use
determin
yearli
chang
incid
densiti
percentag
confid
interv
ci
data
analys
use
spss
spss
inc
chicago
il
r
studi
period
total
nosocomi
bsi
identifi
bsi
infect
caus
aureu
n
due
mrsa
period
incid
densiti
nosocomi
bsi
increas
per
patientday
p
annual
increas
ci
secular
trend
incid
densiti
nosocomi
mrsa
meticillinsuscept
aureu
bsi
shown
fig
mrsa
incid
densiti
significantli
decreas
per
patientday
annual
decreas
ci
studi
period
p
addit
ratio
mrsa
isol
aureu
isol
obtain
patient
nosocomi
bsi
decreas
p
studi
found
incid
nosocomi
mrsa
bsi
decreas
even
though
increas
incid
nosocomi
bsi
taiwan
therefor
total
burden
nosocomi
bsi
like
attribut
pathogen
mrsa
find
contrast
sharpli
report
ammerlann
et
al
consist
european
countri
respons
sever
acut
respiratori
syndrom
sar
epidem
infect
prevent
control
programm
ntuh
upgrad
includ
hand
hygien
antibiot
control
polici
annual
intens
projectbas
control
programm
implement
measur
one
main
reason
decreas
mrsa
infect
studi
period
fact
impact
polici
demonstr
directli
associ
decreas
rate
bsi
ntuh
conclus
result
show
incid
mrsa
nosocomi
bsi
decreas
period
ntuh
infect
control
measur
hospit
like
play
major
role
protect
mrsa
infect
fund
fund
sourc
compet
interest
none
declar
ethic
approv
requir
